Diabetes

Top Story

Abbott to acquire St. Jude Medical

April 28, 2016

Abbott announced that it will acquire St. Jude Medical in an effort to enhance its global scale and diversify its portfolio.

With the acquisition, Abbott will become a “premier medical device leader with top positioning in high-growth [CV] markets, including AF, structural heart and HF as well as a leading position in the high-growth neuromodulation market,” the company stated in a press release.

Meeting News Coverage

PEGASUS-TIMI 54: Long-term ticagrelor benefits patients with history of MI, diabetes, PAD

April 28, 2016
CHICAGO — Two subanalyses of the PEGASUS-TIMI 54 study of stable patients with prior MI showed that ticagrelor reduced major adverse CV events in patients with a…
In the Journals

Lipid-lowering therapy reduces risk for CVD, death in type 1 diabetes

April 26, 2016
People with type 1 diabetes without a history of cardiovascular disease may have reduced risk for cardiovascular disease and cardiovascular death with the use of…
In the Journals

Healthy diet may reduce hypertension risk in women with gestational diabetes

April 21, 2016
Women with gestational diabetes were 20% less likely to develop hypertension later in life if they maintained a healthy diet, researchers reported in…
CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
Video
Meeting News Coverage

VIDEO: Daniel P. Kelly, MD, details ‘vicious cycle’ between obesity, diabetes and CVD

December 15, 2015
More »
Featured
Highlights from ACC Scientific Session

Highlights from ACC Scientific Session

Video
Meeting News Coverage

VIDEO: Positive CV outcomes with SGLT2 inhibitors mark ‘an exciting time’

January 7, 2016
More »
Meeting News CoveragePerspective

EMPA-REG Outcome: Empagliflozin reduces risk for HF endpoints

November 9, 2015
ORLANDO, Fla. — Empagliflozin, an SGLT2 inhibitor, is associated with decreased risk for HF hospitalization or CV death and other HF-related…
In the Journals

Moderate wine intake may reduce cardiometabolic risk in adults with diabetes

November 6, 2015
Moderate consumption of alcohol, especially red wine, in addition to a healthy diet may modestly reduce cardiometabolic risk among patients with…
Meeting News CoveragePerspective

MAJESTIC: DES to treat femoropopliteal lesions shows high patency, low TLR

November 2, 2015
LAS VEGAS — A drug-eluting stent was safe and had a high patency rate in patients with femoropopliteal artery lesions, regardless of whether a…
Meeting News Coverage

Heritability of PCOS provides clues for metabolic risk

October 28, 2015
BOSTON — Polycystic ovary syndrome is the most powerful predictor of type 2 diabetes in young women, but the disorder also offers clues for…
Meeting News Coverage

New diabetes drugs offer more options, some safety concerns

October 27, 2015
BOSTON — New diabetes drugs entering the market provide an increasing number of treatment options for patients living with the disease, making…
Meeting News Coverage

New diabetes technology improves care, but not cure-all

October 24, 2015
BOSTON – New technologic advances have changed the landscape of diabetes management, but effective treatment still comes down to how the…
Meeting News CoverageVideo

VIDEO: Changing landscape of diabetes care explored at CMHC 2015

October 24, 2015
BOSTON — In this video, John B. Buse, MD, PhD, discusses the evolving landscape of care for patients with type 2 diabetes.“There has…
Meeting News CoverageVideo

VIDEO: Today marks 'exciting time at intersection of diabetes and CV medicine'

October 22, 2015
BOSTON — The results of CV outcomes studies of diabetes therapies continue to answer important questions regarding the safety of new treatment…
Meeting News CoverageVideo

VIDEO: Recent advances in diabetes highlighted at Cardiometabolic Health Congress

October 22, 2015
BOSTON — In this video, Jay S. Skyler, MD, MACP, co-chairperson of the Cardiometabolic Health Congress, discusses recent advances in the…
CME

The Patient With Atrial Fibrillation

October 15, 2015 Expires: 10/15/2016
Atrial fibrillation is the most common type of tachyarrhythmia and is characterized by disorganization of the heart’s electrical activity, increasing…
More Headlines »
morganatic-roan